These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 16130520)
1. 4'-Ethynylstavudine (4'-Ed4T) has potent anti-HIV-1 activity with reduced toxicity and shows a unique activity profile against drug-resistant mutants. Tanaka H; Haraguchi K; Kumamoto H; Baba M; Cheng YC Antivir Chem Chemother; 2005; 16(4):217-21. PubMed ID: 16130520 [TBL] [Abstract][Full Text] [Related]
2. From the chemistry of epoxy-sugar nucleosides to the discovery of anti-HIV agent 4'-ethynylstavudine-Festinavir. Haraguchi K; Takeda S; Kubota Y; Kumamoto H; Tanaka H; Hamasaki T; Baba M; Paintsil E; Cheng YC Curr Pharm Des; 2013; 19(10):1880-97. PubMed ID: 23092278 [TBL] [Abstract][Full Text] [Related]
3. Anti-human immunodeficiency virus type 1 activity and resistance profile of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine in vitro. Nitanda T; Wang X; Kumamoto H; Haraguchi K; Tanaka H; Cheng YC; Baba M Antimicrob Agents Chemother; 2005 Aug; 49(8):3355-60. PubMed ID: 16048947 [TBL] [Abstract][Full Text] [Related]
4. Intracellular metabolism and persistence of the anti-human immunodeficiency virus activity of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel thymidine analog. Paintsil E; Dutschman GE; Hu R; Grill SP; Lam W; Baba M; Tanaka H; Cheng YC Antimicrob Agents Chemother; 2007 Nov; 51(11):3870-9. PubMed ID: 17724147 [TBL] [Abstract][Full Text] [Related]
5. Novel 4'-substituted stavudine analog with improved anti-human immunodeficiency virus activity and decreased cytotoxicity. Dutschman GE; Grill SP; Gullen EA; Haraguchi K; Takeda S; Tanaka H; Baba M; Cheng YC Antimicrob Agents Chemother; 2004 May; 48(5):1640-6. PubMed ID: 15105115 [TBL] [Abstract][Full Text] [Related]
6. Impact of novel human immunodeficiency virus type 1 reverse transcriptase mutations P119S and T165A on 4'-ethynylthymidine analog resistance profile. Yang G; Paintsil E; Dutschman GE; Grill SP; Wang CJ; Wang J; Tanaka H; Hamasaki T; Baba M; Cheng YC Antimicrob Agents Chemother; 2009 Nov; 53(11):4640-6. PubMed ID: 19704131 [TBL] [Abstract][Full Text] [Related]
8. Balancing antiviral potency and host toxicity: identifying a nucleotide inhibitor with an optimal kinetic phenotype for HIV-1 reverse transcriptase. Sohl CD; Kasiviswanathan R; Kim J; Pradere U; Schinazi RF; Copeland WC; Mitsuya H; Baba M; Anderson KS Mol Pharmacol; 2012 Jul; 82(1):125-33. PubMed ID: 22513406 [TBL] [Abstract][Full Text] [Related]
9. Highly selective action of triphosphate metabolite of 4'-ethynyl D4T: a novel anti-HIV compound against HIV-1 RT. Yang G; Dutschman GE; Wang CJ; Tanaka H; Baba M; Anderson KS; Cheng YC Antiviral Res; 2007 Mar; 73(3):185-91. PubMed ID: 17109975 [TBL] [Abstract][Full Text] [Related]
10. A conformationally locked analogue of the anti-HIV agent stavudine. An important correlation between pseudorotation and maximum amplitude. Choi Y; George C; Comin MJ; Barchi JJ; Kim HS; Jacobson KA; Balzarini J; Mitsuya H; Boyer PL; Hughes SH; Marquez VE J Med Chem; 2003 Jul; 46(15):3292-9. PubMed ID: 12852759 [TBL] [Abstract][Full Text] [Related]
11. Retention of metabolites of 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine, a novel anti-human immunodeficiency virus type 1 thymidine analog, in cells. Wang X; Tanaka H; Baba M; Cheng YC Antimicrob Agents Chemother; 2009 Aug; 53(8):3317-24. PubMed ID: 19470503 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of inhibition of human immunodeficiency virus type 1 reverse transcriptase by a stavudine analogue, 4'-ethynyl stavudine triphosphate. Yang G; Wang J; Cheng Y; Dutschman GE; Tanaka H; Baba M; Cheng YC Antimicrob Agents Chemother; 2008 Jun; 52(6):2035-42. PubMed ID: 18391035 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, anti-human immunodeficiency virus activity and esterase lability of some novel carboxylic ester-modified phosphoramidate derivatives of stavudine (d4T). McGuigan C; Sutton PW; Cahard D; Turner K; O'Leary G; Wang Y; Gumbleton M; De Clercq E; Balzarini J Antivir Chem Chemother; 1998 Nov; 9(6):473-9. PubMed ID: 9865385 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anti-HIV activity of carbamates of antiviral agent stavudine. Venkatachalam TK; Samuel P; Kourinov IV; Uckun FM Antivir Chem Chemother; 2002 Sep; 13(5):289-97. PubMed ID: 12630677 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and anti-HIV activity of 4'-cyano-2',3'-didehydro-3'-deoxythymidine. Haraguchi K; Itoh Y; Takeda S; Honma Y; Tanaka H; Nitanda T; Baba M; Dutschman GE; Cheng YC Nucleosides Nucleotides Nucleic Acids; 2004; 23(4):647-54. PubMed ID: 15200028 [TBL] [Abstract][Full Text] [Related]
16. New lipophilic derivatives of AZT and d4T 5'-phosphonates. Shirokova EA; Jasko MV; Khandazhinskaya AL; Yanvarev DV; Skoblov YS; Pronayeva TR; Fedyuk NV; Pokrovsky AG; Kukhanova MK Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):981-5. PubMed ID: 14565326 [TBL] [Abstract][Full Text] [Related]
17. Potency of stampidine against multi-nucleoside reverse transcriptase inhibitor resistant human immunodeficiency viruses. Uckun FM; Venkatachalam TK; Qazi S Arzneimittelforschung; 2006 Feb; 56(2A):193-203. PubMed ID: 16570827 [TBL] [Abstract][Full Text] [Related]
18. Synthesis of a highly active new anti-HIV agent 2',3'-didehydro-3'-deoxy-4'-ethynylthymidine. Haraguchi K; Takeda S; Tanaka H; Nitanda T; Baba M; Dutschman GE; Cheng YC Bioorg Med Chem Lett; 2003 Nov; 13(21):3775-7. PubMed ID: 14552777 [TBL] [Abstract][Full Text] [Related]
19. The presence of substituents on the aryl moiety of the aryl phosphoramidate derivative of d4T enhances anti-HIV efficacy in cell culture: A structure-activity relationship. Siddiqui AQ; Ballatore C; McGuigan C; De Clercq E; Balzarini J J Med Chem; 1999 Feb; 42(3):393-9. PubMed ID: 9986709 [TBL] [Abstract][Full Text] [Related]
20. Anti-retroviral activity of GMP-grade stampidine against genotypically and phenotypically nucleoside reverse transcriptase inhibitor resistant recombinant human immunodeficiency virus. An in vitro study. Uckun FM; DuMez D; Qazi S; Tibbles H; Venkatachalam TK Arzneimittelforschung; 2007; 57(2):112-21. PubMed ID: 17396622 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]